Cue biopharma reports first quarter 2025 financial results and recent business highlights

Announced boehringer ingelheim strategic collaboration and license agreement for cue-501, including an upfront payment of $12 million and ~$345 million in potential milestone payments
CUE Ratings Summary
CUE Quant Ranking